
Sign up to save your podcasts
Or


The world's top neurotechnology companies can keep indefinite possession of the data generated by the brains of their trial subjects and customers, and even share it with third parties, according to upcoming research. FRANCE 24's Tech Editor Peter O'Brien tells us more.
By FRANCE 24 English5
44 ratings
The world's top neurotechnology companies can keep indefinite possession of the data generated by the brains of their trial subjects and customers, and even share it with third parties, according to upcoming research. FRANCE 24's Tech Editor Peter O'Brien tells us more.

4 Listeners

1 Listeners

0 Listeners

2 Listeners

1 Listeners

21 Listeners

0 Listeners

4 Listeners

23 Listeners

6 Listeners

5 Listeners

40 Listeners

3 Listeners

4 Listeners

5 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

8 Listeners